Sarepta fa'atauga si'itia sili atu nai lo le 10% i'uga maualuga fa'amoemoega, vaila'au fa'amuamua iloiloga

Sarepta Therapeutics Inc. SRPT sea na faʻaputuina i le faʻaopoopoga o le sauniga Aso Lua ina ua maeʻa le faʻatauga o vailaʻau biotech i luga o le Wall Street faʻamoemoega, ma fai mai na tuʻuina atu e le au faʻatonu a le US se tulaga faʻamuamua iloiloga mo lona sui o vailaʻau faʻamaʻi muscular dystrophy SRP-9001. Sarepta sea na faʻaputuina e oʻo atu i le 14% i le maeʻa ai o itula, i le maeʻa ai o le 3.3% i luga o le sauniga masani e tapunia i le $ 122.13. Na lipotia e le kamupani le leiloa o le kuata lona fa e $109.2 miliona, poo le $1.24 i le sea, pe a faatusatusa i le leiloa e $122 miliona, poo le $1.42 i le sea, i le tausaga ua mavae. O le toe fetuunaiga, lea e le aofia ai tupe faʻaalu faʻavae faʻatau ma isi mea, e 53 sene…

Source: https://www.marketwatch.com/story/sarepta-stock-surges-more-than-10-as-results-top-expectations-drug-given-priority-review-2ab2a319?siteid=yhoof2&yptr=yahoo